GLP-1 receptor agonists in patients on antipsychotic medications?

This article was first published on December 11, 2023. It was last reviewed, updated, or edited on December 11, 2023. There is a lot of excitement about the advent of glucagon-like peptide 1 (GLP-1) receptor agonists in medicine—for the management of diabetes mellitus, obesity, and overweight with at least one weight-related comorbid condition. For other…